According to Hologic's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 29.6231. At the end of 2022 the company had a P/E ratio of 18.9.
Year | P/E ratio | Change |
---|---|---|
2022 | 18.9 | 65.99% |
2021 | 11.4 | -16.5% |
2020 | 13.7 | -75.66% |
2019 | 56.1 | -304.89% |
2018 | -27.4 | -347.4% |
2017 | 11.1 | -67.15% |
2016 | 33.7 | -42.49% |
2015 | 58.6 | -60.54% |
2014 | 149 | -3017.94% |
2013 | -5.09 | -91.35% |
2012 | -58.9 | -315.11% |
2011 | 27.4 | -143.61% |
2010 | -62.7 | 3659.67% |
2009 | -1.67 | -100.38% |
2008 | 436 | -1274.22% |
2007 | -37.1 | -160.43% |
2006 | 61.4 | 10.11% |
2005 | 55.8 | 56.31% |
2004 | 35.7 | -46.23% |
2003 | 66.3 | -83.7% |
2002 | 407 | -4481.05% |
2001 | -9.29 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.